240 related articles for article (PubMed ID: 25824544)
1. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.
Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS
Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544
[TBL] [Abstract][Full Text] [Related]
2. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
3. Association between interleukin 17/interleukin 17 receptor gene polymorphisms and papillary thyroid cancer in Korean population.
Lee YC; Chung JH; Kim SK; Rhee SY; Chon S; Oh SJ; Hong IK; Eun YG
Cytokine; 2015 Feb; 71(2):283-8. PubMed ID: 25484349
[TBL] [Abstract][Full Text] [Related]
4. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG
J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974
[TBL] [Abstract][Full Text] [Related]
5. A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.
Eun YG; Chung DH; Kim SW; Lee YC; Kim SK; Kwon KH
Eur Surg Res; 2014; 52(1-2):1-7. PubMed ID: 24434721
[TBL] [Abstract][Full Text] [Related]
6. PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.
Kim MJ; Kim SK; Park HJ; Chung DH; Park HK; Lee JS; Kwon KH; Chung JH
Mol Med Rep; 2012 May; 5(5):1267-70. PubMed ID: 22327316
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.
Rehman S; Saba N; Naz M; Ahmed P; Munir S; Sajjad S; Tabassum S; Naseem L
Immunol Invest; 2018 Jul; 47(5):484-491. PubMed ID: 29611722
[TBL] [Abstract][Full Text] [Related]
8. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
9. Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.
Eun YG; Kim SK; Chung JH; Kwon KH
Am J Surg; 2013 Jun; 205(6):631-5. PubMed ID: 23388428
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
11. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 22 polymorphisms and papillary thyroid cancer.
Eun YG; Shin IH; Lee YC; Shin SY; Kim SK; Chung JH; Kwon KH
J Endocrinol Invest; 2013 Sep; 36(8):584-7. PubMed ID: 23448944
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
14. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
15. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
[TBL] [Abstract][Full Text] [Related]
16. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
17. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.
Kwon KH; Lee YC; Chung JH; Eun YG
J Invest Surg; 2013 Dec; 26(6):319-24. PubMed ID: 23957698
[TBL] [Abstract][Full Text] [Related]
18. Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.
Zhang Q; Song F; Zheng H; Zhu X; Song F; Yao X; Zhang L; Chen K
Thyroid; 2013 Jan; 23(1):38-44. PubMed ID: 22973979
[TBL] [Abstract][Full Text] [Related]
19. Association of the ATM gene polymorphisms with papillary thyroid cancer.
Gu Y; Yu Y; Ai L; Shi J; Liu X; Sun H; Liu Y
Endocrine; 2014 Apr; 45(3):454-61. PubMed ID: 23925578
[TBL] [Abstract][Full Text] [Related]
20. Single Nucleotide Polymorphism of Interleukin-18 and Interleukin-18 Receptor and the Risk of Papillary Thyroid Cancer.
Chung JH; Lee YC; Eun YG; Chung JH; Kim SK; Chon S; Oh SJ; Rhee SY; Hong IK
Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):598-603. PubMed ID: 26600055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
